2021 年第 10 期 第 16 卷

基于网络药理学探讨复方伤痛胶囊治疗急性软组织损伤的有效活性成分及作用机制

Active components and mechanism of Fufang Shangtong capsules in treatment of acute soft tissue injury based on network pharmacology

作者：王肖辉1周霖2许静3李砺锋2焦鹏飞4薛文华2孙志2左莉华2金建文5武婧5赵杰2付智慧6

英文作者：Wang Xiaohui1 Zhou Lin2 Xu Jing3 Li Lifeng2 Jiao Pengfei4 Xue Wenhua2 Sun Zhi2 Zuo Lihua2 Jin Jianwen5 Wu Jing5 Zhao Jie2 Fu Zhihui6

单位：1郑州大学第一附属医院超声科450052；2郑州大学第一附属医院药学部450052；3上海市闵行区梅陇社区卫生服务中心全科医学科201104；4郑州大学第一附属医院呼吸科450052；5陕西丽彩药业有限公司市场部，陕西省咸阳市712000；6郑州大学第一附属医院中医药学部450052

英文单位：1Department of Ultrasonography the First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 China; 2Department of Pharmacy the First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 China; 3Department of General Medicine Meilong Community Health Service Center of Minhang District Shanghai 201104 China; 4Department of Respiratory the First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 China; 5Department of Marketing Shaanxi Licai Pharmacy Co. Ltd. Shaanxi Province Xianyang 712000 China; 6Department of Traditional Chinese Medicine the First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 China

关键词：急性软组织损伤；网络药理学；复方伤痛胶囊；作用机制

英文关键词：Acutesofttissueinjury;Networkpharmacology;FufangShangtongcapsules;Mechanism

• 摘要：

• 目的  采用网络药理学方法研究复方伤痛胶囊治疗急性软组织损伤的有效活性成分及主要作用机制。方法采用中药系统药理学数据库和分析平台、UniPort、DrugBank数据库检索复方伤痛胶囊的主要化学成分及作用靶点；基于DisGeNET、DrugBank、OMIM及Genecards数据库获取急性软组织损伤的相关靶点；将复方伤痛胶囊与急性软组织损伤的靶点取交集，获取复方伤痛胶囊治疗急性软组织损伤的直接靶点；利用STRING数据库得到蛋白相互作用关系；使用DAVID数据库进行基因本体论富集分析和KEGG通路分析（设置P<0.05）；采用Cytoscape 3.7.2软件构建蛋白相互作用网络、“药物-活性成分-靶点”网络以及“活性成分-重要靶点-关键通路”网络，并进行相关网络分析。结果 本研究初步筛选复方伤痛胶囊209个成分和238个靶点；急性软组织损伤4 347个靶点，药物-疾病交集靶点173个；最终得到药物的主要有效活性成分有木犀草素、山柰酚、槲皮素、β-谷甾醇、黄芩素等；关键靶点为前列腺素内过氧化物合酶2（PTGS2）、热休克蛋白90AA1、PTGS1、一氧化氮合酶2、过氧化物酶体增殖物激活受体γ等；映射的靶标通路为磷脂酰肌醇-3-激酶-蛋白激酶B信号通路、肿瘤坏死因子信号通路、破骨细胞分化等；涉及的生物过程主要有细胞因子的反应、细胞外调节蛋白激酶1和2级联的正调控、炎症反应等。结论 复方伤痛胶囊主要有效活性成分有木犀草素、山柰酚等，通过抑制炎症反应、促进组织损伤修复及缓解疼痛等起到治疗急性软组织损伤的作用。

• Objective To investigate the active components and mechanism of Fufang Shangtong capsules in treatment of acute soft tissue injury by network pharmacology. Methods The main chemical components and targets of Fufang Shangtong capsules were screened via Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, UniPort, and DrugBank databases. The related targets of acute soft tissue injury were retrieved via DisGeNET, DrugBank, OMIM and Genecards databases. The direct targets of Fufang Shangtong capsules in treatment of acute soft tissue injury were obtained by crossing the targets of Fufang Shangtong capsules and acute soft tissue injury. Protein-protein interaction(PPI) relationship was obtained by STRING database. Gene ontology enrichment analysis and KEGG pathway analysis were conducted by DAVID database (setting P<0.05). Cytoscape 3.7.2 software was used to construct and analyze the networks of PPI, "medicine-active components-targets" and "active components-important targets-critical pathways". Results There were 209 components and 238 targets of Fufang Shangtong capsules screened preliminarily in  this study. There were 4 347 targets of acute soft tissue injury and 173 targets of drug-disease intersection. The main active components of the drug were obtained, including luteolin, kaempferol, quercetin, β-sitosterol, baicalein, etc. The key targets were prostaglandin-endoperoxide synthase 2 (PTGS2), heat shock protein 90AA1, PTGS1, nitric oxide synthase 2, peroxisome proliferator receptor γ, etc. The mapped target pathways were phosphatidylinositol-3-kinase-protein kinase B signaling pathway, tumor necrosis factor signaling pathway, osteoclast differentiation, etc. The main biological processes involved cytokine response, positive regulation of extracellular signal-regulated kinase 1 and 2 cascade, inflammatory response, etc. Conclusions  The main active components of Fufang Shangtong capsules are luteolin and kaempferol, etc. The treatment of acute soft tissue injury is mainly through inhibiting inflammatory response, promoting the repair of tissue damage and relieving pain.